Last reviewed · How we verify
KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
This is an open-label, phase II study of KN046 combined with chemotherapy and palliative radiotherapy in patients with recurrent or metastatic esophageal squamous cell carcinoma to evaluate the safety, efficacy and tolerance.
Details
| Lead sponsor | Shanghai Chest Hospital |
|---|---|
| Phase | PHASE2 |
| Status | UNKNOWN |
| Enrolment | 100 |
| Start date | Wed May 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Dec 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Esophageal Squamous Cell Carcinoma
Interventions
- KN046
- palliative radiotherapy
- KN046
Countries
China